Stock Surge: Relay Therapeutics Inc (RLAY) Closes at 7.27, Marking a -0.95 Increase/Decrease

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

In the latest session, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $7.27 down -0.95% from its previous closing price of $7.34. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 1.63 million shares were traded. RLAY stock price reached its highest trading level at $7.865 during the session, while it also had its lowest trading level at $7.254.


For a deeper understanding of Relay Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.

Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 05 ’24 when Rahmer Peter sold 20,450 shares for $7.06 per share. The transaction valued at 144,377 led to the insider holds 432,425 shares of the business.

Rahmer Peter sold 40,595 shares of RLAY for $269,551 on Jun 04 ’24. The insider now owns 452,875 shares after completing the transaction at $6.64 per share. On Jun 03 ’24, another insider, Rahmer Peter, who serves as the insider of the company, sold 19,864 shares for $6.47 each. As a result, the insider received 128,520 and left with 493,470 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 974325376 and an Enterprise Value of 267729984. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.31 while its Price-to-Book (P/B) ratio in mrq is 1.29. Its current Enterprise Value per Revenue stands at 7.579 whereas that against EBITDA is -0.736.

Stock Price History:

Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is 6.61%, while the 200-Day Moving Average is calculated to be -15.62%.

Shares Statistics:

For the past three months, RLAY has traded an average of 1.27M shares per day and 1258920 over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 91.19M. Insiders hold about 31.30% of the company’s shares, while institutions hold 72.52% stake in the company. Shares short for RLAY as of 1715731200 were 11885608 with a Short Ratio of 9.35, compared to 1713139200 on 10692091. Therefore, it implies a Short% of Shares Outstanding of 11885608 and a Short% of Float of 11.5.

Most Popular